<\/p>\n
Medicare beneficiaries may soon have a much more affordable path to GLP-1 medications. Starting July 1, 2026, eligible enrollees can access drugs like Wegovy and Zepbound for a flat $50 monthly copay through a new pilot initiative called the Medicare GLP-1 Bridge program. According to a release by the Center for Medicare and Medicade Services, the program runs through December 31, 2027, and is designed to bridge the gap while a longer-term coverage plan is worked out.<\/p>\n
To qualify, you must be enrolled in a Medicare Part D plan and meet certain health criteria, either a BMI of 27 or higher with a comorbidity like heart disease or prediabetes, or a BMI of 35 or higher regardless of other conditions. <\/p>\n<\/div>\n
Eligible medications include injectable and pill forms of Wegovy, and the KwikPen form of Zepbound along with Foundayo, the latest GLP-1 pill to be approved. Notably, doctors don’t need to be enrolled as Medicare providers to write a prescription under this program.<\/p>\n
The savings are significant given that current cash prices for GLP-1 medications typically run anywhere from $149 to $699 per month even with discounts. The Bridge program’s $50 copay stays flat regardless of dosage, which is important because the average user will need higher doses if they\u2019ve already been taking the medication or are in maintenance mode.<\/p>\n
There are a few trade-offs to report. For one, the copay doesn’t count toward the standard Part D deductible or annual out-of-pocket cap. Also those on the low-income Medicare Extra Help subsidy won’t be able to apply that assistance to Bridge program prescriptions.<\/p>\n
What happens after 2027 is still uncertain. The program was initially designed to run for six months, but after too few insurance companies agreed to participate in a voluntary extension, the government stepped in and expanded it to 18 months. This gives everyone more time to negotiate a permanent solution, but the costs are no joke\u2014experts estimate it could end up costing Medicare billions of dollars every year based on how many people use it.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"
Medicare beneficiaries may soon have a much more afford […]<\/p>\n","protected":false},"author":1,"featured_media":1691,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"_links":{"self":[{"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/posts\/1690"}],"collection":[{"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/comments?post=1690"}],"version-history":[{"count":0,"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/posts\/1690\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/media\/1691"}],"wp:attachment":[{"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/media?parent=1690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/categories?post=1690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nichebeaty.com\/index.php\/wp-json\/wp\/v2\/tags?post=1690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}